The pH of a solution prepared from the water-soluble composition or a peptide salt of the present invention should be such that said pH will not exert any adverse influence upon the activity of the pharmacologically active peptide, but is within an acceptable range for injections in general and further, such that said pH will neither cause a great change in viscosity of the solution nor allow formation of a precipitate or the like
Additionally, prodrugs like PR104A and OBI-3424, activated by AKR1C3, exhibit efficacy in preclinical models of T-ALL
Available from: [10] Kasbo J, Tuchweber B, Perwaiz S, Bouchard G, Lafont H, Domingo N, et al
Persistence and outcomes are not just about access to medicationtheyre about helping people build routines, confidence, and momentum, said Cook
Record the daily weight but focus on the weekly average
and Liby, K.T., NRF2 and cancer: the good, the bad and the importance of context